NCT06763081View on ClinicalTrials.gov

Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

RecruitingOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2030

Conditions
Behavioral ActivationMajor Depressive DisorderAnxiety DisordersAntidepressant Drug Adverse ReactionObsessive Compulsive Disorder (OCD)Major Depression
Interventions
OTHER

Not applicable- observational study

It's an observational study. Participants are not assigned an intervention as part of the study.

Trial Locations (2)

R3C 3H8

RECRUITING

Shared Health Facilities, Winnipeg

R3E 0T5

RECRUITING

University of Manitoba College of Pharmacy, Winnipeg

All Listed Sponsors
collaborator

Health Sciences Centre Foundation, Manitoba

OTHER

collaborator

Children's Hospital Research Institute of Manitoba

OTHER

collaborator

University of Calgary Cumming School of Medicine

UNKNOWN

lead

University of Manitoba

OTHER